Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

21.10
-1.9900-8.62%
Post-market: 21.360.2600+1.23%17:35 EDT
Volume:151.80K
Turnover:3.27M
Market Cap:32.04M
PE:- -
High:22.94
Open:21.79
Low:20.67
Close:23.09
52wk High:152.22
52wk Low:11.52
Shares:1.52M
Float Shares:1.52M
Volume Ratio:0.96
T/O Rate:10.00%
Dividend:3.85
Dividend Rate:18.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Biovica Shifts US Strategy to Prioritize Commercial Channels with Faster Revenue Path

Reuters
·
Jun 30

Tempus AI CFO James William Rogers Sells 11,529 Common Shares for $634,095

Reuters
·
Jun 30

AI Software Shares Rise. Roblox up over 12%; AppLovin up About 5%; Palantir, TEAM up About 4%; DataDog, ServiceNow up over 3%

Tiger Newspress
·
Jun 29

tempus AI Inc Class A call volume above normal and directionally bullish

TIPRANKS
·
Jun 25

Tempus AI Launches Angiosarcoma Research Collaboration with Angiosarcoma Awareness

Reuters
·
Jun 25

Anthropic’S Mythos Model Uncovers US Intelligence Vulnerabilities Within Hours; Demonstrates Potent Cyber Defense And Offense Capabilities

AI Industry Frontlines
·
Jun 24

BofA Warns: AI Bubble Flashes Historic Danger Signals

AI Industry Frontlines
·
Jun 22

Can Tempus AI’s (TEM) New ECG-AF Validation Deepen Its Edge in Clinical-Grade Healthcare AI?

Simply Wall St.
·
Jun 21

Tempus AI says multi-center study validates FDA-cleared ECG model predicting 1-year atrial fibrillation risk

Reuters
·
Jun 11

Tempus unit Ambry study finds ExomeReveal RNA testing boosts clarity for uncertain exome results

Reuters
·
Jun 09

If AI Healthcare Wins Big These Three Stocks Could Matter

Simply Wall St.
·
Jun 08

Skip the Oura Ring IPO. Buy These 10 Stocks Instead.

InvestorPlace
·
Jun 07

Is Tempus AI’s (TEM) New Oncology Tools Quietly Redefining Its Precision Medicine Moat?

Simply Wall St.
·
Jun 06

Tempus AI director David R. Epstein reports disposal of 250 common shares worth $12,350

Reuters
·
Jun 04

Tempus AI launches open-source digital pathology consortium

TIPRANKS
·
Jun 03

Tempus AI assumed with a Peer Perform at Wolfe Research

TIPRANKS
·
Jun 02

Tempus AI announced the upcoming clinical availability of xH

TIPRANKS
·
Jun 01

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, Xh

THOMSON REUTERS
·
Jun 01

Guggenheim Reaffirms Their Buy Rating on Tempus AI, Inc. Class A (TEM)

TIPRANKS
·
Jun 01

Tempus AI Price Target Maintained With a $80.00/Share by BTIG

Dow Jones
·
Jun 01